This report provides a summary of the Bristol & Severn ODN Workshop held by HCV Action, in partnership with the ODN, in Bristol on 14th September 2017. The workshop brought together a range of stakeholders working across the hepatitis C pathway in the Bristol & Severn ODN region, with the aim of discussing some of the barriers faced by the ODN, as well as providing a forum in which to develop solutions to some of these challenges. The report includes summaries of the day's talks and group discussion, as well as suggested next steps to be taken following the event.
Resources
Drug services professional
Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country. Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.
Showing 71 to 80 of 233 resources
-
Summary report: Bristol & Severn ODN workshop, Bristol
South West Reports & Research PDF -
Understanding the pathway: barriers to data collection and onward referral to specialist hepatitis C services for PWID in London
This report, from the London Joint Working Group on Substance Use and Hepatitis C, examines barriers to data collection and onward referral to specialist hepatitis C services for people who inject drugs in London.England, Greater London Reports & Research PDF -
Summary report: Hepatitis C good practice roadshow, Leeds - September 2017
This report provides a summary of the good practice hepatitis C roadshow held by HCV Action and Public Health England in Cambridge on 6th September 2017. The roadshows are an annual series of events aiming to bring together professionals working with hepatitis C in a variety of contexts, identify challenges and solutions for tackling hepatitis C locally, and showcase and share examples of good practice in prevention, testing, and treatment. The report includes summaries of the talks and workshops held on the day and attendees' reflections on the day.UK, England, Yorkshire and the Humber Reports & Research PDF -
HCV Action and PHE hepatitis C roadshow in Leeds: Presentations
On 6th September 2017, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Leeds. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Leeds and the wider West Yorkshire region.UK, England, Yorkshire and the Humber Other, Strategy & Planning PDF -
Good practice case study: Oxford Liaison Service outreach
This HCV Action good practice case study looks at the community outreach work done by Oxford University Hospitals NHS Foundation Trust. A survey of injecting drug users in the Oxfordshire area to determine levels of hepatitis C testing found that a third of responders had never been tested for hepatitis C. Following the survey results, the Trust established a Liaison Service, training substance misuse staff to test clients for hepatitis C, referring patients to secondary care and, in some cases, treating patients in the community.UK, South East Case study PDF -
Road to Elimination: Barriers and Best Practices in Hepatitis C Management
This report provides an overview of the status of HCV care in Europe and Australia. Through literature review and country experts’ consultation conducted between November 2016 and March 2017, the report analyses the status of 11 countries, identifying and comparing key success factors and main barriers for each step of the HCV care cascade: (1) awareness and prevention; (2) testing and diagnosis; (3) linkage to care and access to qualified health services; (4) access to medication; and (5) monitoring and evaluation.UK, Rest of World Reports & Research, Strategy & Planning PDF -
Unlinked anonymous HIV and viral hepatitis monitoring among PWID: 2017 report
This report presents an overview of the trends between 2006 and 2016 for HIV, hepatitis B, hepatitis C and risk behaviours from the ongoing Unlinked Anonymous Monitoring Survey, which is targeted at people who inject psychoactive drugs, such as heroin, crack cocaine and amphetamines.UK Reports & Research PDF -
Hepatitis C in the UK 2017 report
The ninth Hepatitis C in the UK report follows the WHO Global Health Sector Strategy (GHSS) on Viral Hepatitis 2016-2021 and the draft action plan for the health sector response to viral hepatitis in the WHO European region. The report is structured to support UK monitoring of the GHSS goals and summarises the impact of UK action plans to drive down mortality from HCV and reduce the number of new infections.UK Reports & Research, Strategy & Planning PDF -
Financial case for action on liver disease
This report, produced by the Foundation for Liver Research and endorsed by the Lancet Commission on Liver Disease, examines the financial costs of viral hepatitis, along with alcohol misuse and obesity. The report also carries recommendations, which include improving access to testing for hepatitis C and protecting harm reduction services such as needle exchange and opioid substitution for injecting drug users.UK Reports & Research PDF -
Summary report: North East & Cumbria ODN Workshop, Newcastle
This report provides a summary of the North East & Cumbria ODN Workshop held by HCV Action, in partnership with the ODN, in Newcastle on Wednesday 3rd May 2017. The workshop brought together a range of stakeholders working across the hepatitis C pathway in the North East & Cumbria ODN region, with the aim of discussing some of the barriers faced by the ODN, as well as providing a forum in which to develop solutions to some of these challenges. The report includes summaries of the day's talks and group discussion, as well as suggested next steps to be taken following the event.North East, UK Reports & Research PDF